Thus, a novel pro-migration mechanism driven by the crosstalk between cisplatin and CAMs, allow to consider the CCL20-CCR6 axis for therapeutic targeting to reduce chemotherapy-induced metastasis in advanced stage ovarian cancer (230). The gene discussed is CCL20; the disease is ovarian carcinoma.